• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然产物作为治疗SARS-CoV2感染的新型药物来源。

Natural products as a source of novel drugs for treating SARS-CoV2 infection.

作者信息

Isidoro Ciro, Chiung-Fang Chang Ashley, Sheen Lee-Yan

机构信息

Università del Piemonte Orientale, Department of Health Sciences, Novara, Italy.

National Taiwan University, Institute of Food Science and Technology, Taipei, Taiwan.

出版信息

J Tradit Complement Med. 2022 Jan;12(1):1-5. doi: 10.1016/j.jtcme.2022.02.001. Epub 2022 Feb 8.

DOI:10.1016/j.jtcme.2022.02.001
PMID:35155135
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8822970/
Abstract

COVID-19, the infectious disease caused by the beta-corona virus SARS-CoV2, has posed a global health threat causing more than five million of deaths in the last two years in the world. Although the disease often presents with mild cold-like symptoms, it may have lethal consequences following thromboembolisms, hyperinflammation and cytokine storm eventually leading to pulmonary fibrosis and multiple organ failure. Despite the progress made in the understanding of the SARS-CoV2 pathology and the clinical management of COVID-19, the viral illness is still a health concern since outbreaks continue to resurge due to the emergence of mutant variants of the virus that resist the vaccines. Therefore, there is an urgent need for therapeutics that can block SARS-CoV2 viral transmission and the progression from infection to severe symptomatic illness. Natural products could be a valuable source of drugs for the management of COVID-19 disease, particularly because they can act on multitargets and through different mechanisms including inhibition of biochemical pathways, epigenetic regulation of gene expression, modulation of immune response, regulation of pathophysiological stress response. Here we present an overview of the natural products that possess SARS-CoV2 antiviral activity and the potential to benefit the management of COVID-19.

摘要

新冠病毒病(COVID-19)是由β冠状病毒严重急性呼吸综合征冠状病毒2(SARS-CoV-2)引起的传染病,在过去两年里对全球健康构成了威胁,已导致全球超过500万人死亡。尽管该病通常表现为类似感冒的轻微症状,但在发生血栓栓塞、过度炎症反应和细胞因子风暴后可能产生致命后果,最终导致肺纤维化和多器官衰竭。尽管在了解SARS-CoV-2病理和COVID-19临床管理方面取得了进展,但由于抵抗疫苗的病毒突变变种的出现,疫情仍不断复发,这种病毒性疾病仍是一个健康问题。因此,迫切需要能够阻断SARS-CoV-2病毒传播以及从感染发展到严重症状性疾病进程的治疗方法。天然产物可能是治疗COVID-19疾病的宝贵药物来源,特别是因为它们可以作用于多个靶点,并通过不同机制发挥作用,包括抑制生化途径、基因表达的表观遗传调控、免疫反应的调节、病理生理应激反应的调节。在此,我们概述了具有抗SARS-CoV-2病毒活性且有可能有助于COVID-19治疗的天然产物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/8888344/dd68481ec8af/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/8888344/d4f3634122a8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/8888344/dd68481ec8af/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/8888344/d4f3634122a8/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1836/8888344/dd68481ec8af/gr1.jpg

相似文献

1
Natural products as a source of novel drugs for treating SARS-CoV2 infection.天然产物作为治疗SARS-CoV2感染的新型药物来源。
J Tradit Complement Med. 2022 Jan;12(1):1-5. doi: 10.1016/j.jtcme.2022.02.001. Epub 2022 Feb 8.
2
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.宿主对 SARS-CoV2 及现有肝脏和胃肠道疾病中新兴变异株的反应。
Front Cell Infect Microbiol. 2021 Oct 25;11:753249. doi: 10.3389/fcimb.2021.753249. eCollection 2021.
3
Can natural products modulate cytokine storm in SARS-CoV2 patients?天然产物能否调节新冠病毒患者的细胞因子风暴?
Biotechnol Rep (Amst). 2022 Sep;35:e00749. doi: 10.1016/j.btre.2022.e00749. Epub 2022 Jun 9.
4
COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.新型冠状病毒肺炎:从 SARS-CoV-2 的结构和复制周期到其疾病症状和治疗方法。
J Physiol Pharmacol. 2021 Aug;72(4). doi: 10.26402/jpp.2021.4.01. Epub 2021 Dec 31.
5
Glycopeptides as Potential Interventions for COVID-19.糖肽类作为新冠病毒病的潜在干预措施
Biologics. 2020 Oct 13;14:107-114. doi: 10.2147/BTT.S262705. eCollection 2020.
6
RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2.通过抑制严重急性呼吸综合征冠状病毒2(SARS-CoV2),利用RNA干扰介导的小干扰RNA(siRNA)序列来抗击2019冠状病毒病疫情。
Gene Rep. 2022 Mar;26:101512. doi: 10.1016/j.genrep.2022.101512. Epub 2022 Jan 15.
7
GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.GSK-3 抑制作为一种治疗 SARS-CoV-2 的方法:抑制病毒复制和增强免疫反应的双重益处。
Front Immunol. 2020 Jun 26;11:1638. doi: 10.3389/fimmu.2020.01638. eCollection 2020.
8
Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis.新型严重急性呼吸综合征冠状病毒 2(SARS-CoV2)和其他冠状病毒:全基因组比较注释与分析。
Mol Cell Biochem. 2021 May;476(5):2203-2217. doi: 10.1007/s11010-020-04027-8. Epub 2021 Feb 10.
9
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
10
Scope of herbal disinfectants to fight against SARS-CoV2 virus.草药消毒剂对抗 SARS-CoV2 病毒的范围。
Trop Biomed. 2021 Dec 1;38(4):605-612. doi: 10.47665/tb.38.4.104.

引用本文的文献

1
The Binding of Brazilin from to the Full-Length SARS-CoV-2 Spike Proteins.来自[具体来源]的巴西苏木素与全长严重急性呼吸综合征冠状病毒2刺突蛋白的结合。
Int J Mol Sci. 2025 Apr 25;26(9):4100. doi: 10.3390/ijms26094100.
2
Non-linear oral bioavailability and clinical pharmacokinetics of high-dose ethanolic extract: relevant dosage implications for COVID-19 treatment.高剂量乙醇提取物的非线性口服生物利用度和临床药代动力学:对COVID-19治疗的相关剂量影响
Pharm Biol. 2025 Dec;63(1):42-52. doi: 10.1080/13880209.2024.2444446. Epub 2025 Jan 6.
3
Potential of traditional medicines in alleviating COVID-19 symptoms.
传统药物在缓解新冠病毒疾病症状方面的潜力。
Front Pharmacol. 2024 Sep 26;15:1452616. doi: 10.3389/fphar.2024.1452616. eCollection 2024.
4
Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19.基于结构的虚拟筛选方法鉴定新型植物化学抑制剂靶向 furin 蛋白酶用于 COVID-19 的治疗。
Front Cell Infect Microbiol. 2024 Jun 11;14:1391288. doi: 10.3389/fcimb.2024.1391288. eCollection 2024.
5
Safety and Efficacy of the Ayurvedic Formulation Guduchi Ghana Vati as a Preventive Remedy in COVID-19.印度草医学配方古杜奇加纳瓦蒂作为COVID-19预防药物的安全性和有效性
Cureus. 2024 Apr 23;16(4):e58807. doi: 10.7759/cureus.58807. eCollection 2024 Apr.
6
Repositioned Natural Compounds and Nanoformulations: A Promising Combination to Counteract Cell Damage and Inflammation in Respiratory Viral Infections.重定位天然化合物和纳米制剂:一种有前途的组合,可抵抗呼吸道病毒感染中的细胞损伤和炎症。
Molecules. 2023 May 12;28(10):4045. doi: 10.3390/molecules28104045.
7
Omicron SARS-CoV-2 Variants in an Genomic Comparison Study with the Original Wuhan Strain and WHO-Recognized Variants of Concern.奥密克戎 SARS-CoV-2 变异株与原始武汉株及世界卫生组织认定的关切变异株的基因组比较研究。
Pol J Microbiol. 2022 Dec 21;71(4):577-587. doi: 10.33073/pjm-2022-053. eCollection 2022 Dec 1.
8
In silico evaluation of Philippine Natural Products against SARS-CoV-2 Main Protease.计算机模拟评估菲律宾天然产物对 SARS-CoV-2 主蛋白酶的抑制作用。
J Mol Model. 2022 Oct 7;28(11):345. doi: 10.1007/s00894-022-05334-1.
9
Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2.利用 SARS-CoV-2 的生物学和化学特性了解和抗击 COVID-19。
Bioprocess Biosyst Eng. 2022 Nov;45(11):1753-1769. doi: 10.1007/s00449-022-02788-8. Epub 2022 Sep 20.
10
Anti-Inflammatory Constituents of on RAW 264.7 Cells Induced by Polyinosinic-Polycytidylic Acid.聚肌胞诱导 RAW264.7 细胞产生的抗炎成分。
Molecules. 2022 Aug 20;27(16):5320. doi: 10.3390/molecules27165320.